Cargando…

Uremic solutes and risk of end stage renal disease in type 2 diabetes

Here we studied plasma metabolomic profiles as determinants of progression to ESRD in patients with Type 2 diabetes (T2D). This nested case-control study evaluated 40 cases who progressed to ESRD during 8-12 years of follow-up and 40 controls who remained alive without ESRD from the Joslin Kidney St...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niewczas, Monika A, Sirich, Tammy L, Mathew, Anna V, Skupien, Jan, Mohney, Robert P, Warram, James H, Smiles, Adam, Huang, Xiaoping, Walker, Walker, Byun, Jaeman, Karoly, Edward D, Kensicki, Elizabeth M, Berry, Gerard T, Bonventre, Joseph V, Pennathur, Subramaniam, Meyer, Timothy W, Krolewski, Andrzej S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072128/ https://www.ncbi.nlm.nih.gov/pubmed/24429397 http://dx.doi.org/10.1038/ki.2013.497

Ejemplares similares

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)

Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes
por: Nowak, Natalia, et al.
Publicado: (2016)

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease
por: Skupien, Jan, et al.
Publicado: (2012)

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria
por: Krolewski, Andrzej S., et al.
Publicado: (2014)

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria
por: Skupien, Jan, et al.
Publicado: (2014)

Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis
por: Mathew, Anna V, et al.
Publicado: (2015)

Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy
por: Pezzolesi, Marcus G., et al.
Publicado: (2013)

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline
por: Wanic, Krzysztof, et al.
Publicado: (2013)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Uremic Toxin Clearance and Cardiovascular Toxicities
por: Mair, Robert D., et al.
Publicado: (2018)

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1
por: Lee, Jung Eun, et al.
Publicado: (2013)

An Enlarged Profile of Uremic Solutes
por: Tanaka, Hisae, et al.
Publicado: (2015)

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies
por: Wanic, Krzysztof, et al.
Publicado: (2008)

Metabolomic analysis of uremic pruritus in patients on hemodialysis
por: Bolanos, Christian G., et al.
Publicado: (2021)

Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis
por: Mathew, Anna V., et al.
Publicado: (2020)

Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
por: Mathew, Anna V., et al.
Publicado: (2018)

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390
por: Niewczas, Monika A., et al.
Publicado: (2017)

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes
por: Perkins, Bruce A., et al.
Publicado: (2012)

Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Supports Its Role as a Susceptibility Gene in Diabetic Nephropathy
por: Pezzolesi, Marcus G., et al.
Publicado: (2009)

High-Density Single Nucleotide Polymorphism Genome-Wide Linkage Scan for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes: Discordant Sibpair Approach
por: Rogus, John J., et al.
Publicado: (2008)

Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease
por: Afshinnia, Farsad, et al.
Publicado: (2020)

Metabolomic Profile of Hepatitis C Virus-Infected Hepatocytes
por: Roe, Barbara, et al.
Publicado: (2011)

Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437
por: Mathew, Anna V., et al.
Publicado: (2019)

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type-1 diabetes
por: Merchant, Michael L., et al.
Publicado: (2013)

Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease
por: Sas, Kelli M, et al.
Publicado: (2015)

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018)

High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up
por: Ficociello, Linda H., et al.
Publicado: (2010)

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes
por: PAVKOV, MEDA E., et al.
Publicado: (2014)

The Hemodialysis Prescription: Past, Present, and Future
por: Murea, Mariana, et al.
Publicado: (2023)

A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes
por: Niewczas, Monika A., et al.
Publicado: (2019)

Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies
por: Leong, Sheldon C., et al.
Publicado: (2016)

Altered HDL proteome predicts incident CVD in chronic kidney disease patients
por: Shao, Baohai, et al.
Publicado: (2021)

Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes
por: Pezzolesi, Marcus G., et al.
Publicado: (2015)

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
por: Ficociello, Linda H., et al.
Publicado: (2009)

Improving Solute Clearances by Hemodialysis
por: Lee, Seolhyun, et al.
Publicado: (2022)

Uremic frost
por: Mathur, Mohit, et al.
Publicado: (2014)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes
por: Pavkov, Meda E., et al.
Publicado: (2016)

Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes
por: Mathew, Anna V., et al.
Publicado: (2019)

Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes
por: Afshinnia, Farsad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h3mfcfl93r193he01vvmr3paa1